Favipiravir is a broad-spectrum oral antiviral agent that shows in vitro activity against SARS-CoV-2.
Presently, data on the real-world effectiveness and optimal dosage of favipiravir for …

Introduction Online, supervised, HIV self‐testing has potential to reach men who have sex
with men (MSM) and transgender women (TGW) who never tested before and who had high …

Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). Although Thailand has been fairly effective at controlling the …

Rationale There is an urgent need for rapid, non-sputum point-of-care diagnostics to detect
tuberculosis. Objectives This prospective trial in seven high tuberculosis burden countries set …

Background Data informing the use of boosted protease inhibitor (PI) monotherapy as
second-line treatment are limited. There are also no randomized trials addressing treatment …

Background Thai patients with HIV have higher exposure to HIV protease inhibitors than do
white people and dose reduction might be possible. We compared the efficacy of low-dose …

Introduction Among high tuberculosis (TB) and HIV burden countries in Asia, tuberculosis
preventive therapy (TPT) in people living with HIV (PLWH) has been underutilized despite its …

Background We studied prevalence of etravirine (ETR) and rilpivirine (RPV) resistance in
HIV-1 subtype CRF01_AE infection with first-line non-nucleoside reverse transcriptase …

Objective: Combination antiretroviral therapy (cART) can suppress plasma HIV RNA to
undetectable levels; yet reports indicate persistent HIV-associated neurocognitive disorders (…

Background The conventional antibiotic regimen for community-acquired upper urinary tract
infections with moderate severity in Thailand is parenteral ceftriaxone (CTRX) for several …